Skip to main content

Table 3 Absolute standardized differences before and after propensity score matching

From: Serum GGT/ALT ratio predicts vascular invasion in HBV-related HCC

Variables

Before matching

SD

After matching

SD

Low (n = 365)

High (n = 193)

Low (n = 93)

High (n = 93)

Age, n (%)

  

0.003

  

0.077

  ≤ 60

291 (75.58)

131 (75.72)

 

73 (78.49)

70 (75.27)

 

  > 60

94 (24.42)

42 (24.28)

 

20 (21.51)

23 (24.73)

 

Sex, n (%)

  

0.302

  

0.032

 Female

70 (18.18)

14 (8.09)

 

12 (12.90)

13 (13.98)

 

 Male

315 (81.82)

159 (91.91)

 

81 (87.10)

80 (86.02)

 

ALT, n(%)

  

0.727

  

 < 0.001

  ≤ 56

299 (77.66)

172 (99.42)

 

92 (98.92)

92 (98.92)

 

  > 56

86 (22.34)

1 (0.58)

 

1 (1.08)

1 (1.08)

 

Albumin, n (%)

  

0.184

  

0.086

  ≤ 40

211 (54.81)

79 (45.66)

 

49 (52.69)

45 (48.39)

 

  > 40

174 (45.19)

94 (54.34)

 

44 (47.31)

48 (51.61)

 

TB, n (%)

  

0.054

  

0.077

  ≤ 20

349 (90.65)

154 (89.02)

 

86 (92.47)

84 (90.32)

 

  > 20

36 (9.35)

19 (10.98)

 

7 (7.53)

9 (9.68)

 

AFP, n (%)

  

0.086

  

0.023

  ≤ 400

282 (73.25)

120 (69.36)

 

65 (69.89)

64 (68.82)

 

  > 400

103 (26.75)

53 (30.64)

 

28 (30.11)

29 (31.19)

 

Cirrhosis, n (%)

  

0.021

  

0.132

 No

79 (20.52)

37 (21.39)

 

17 (18.28)

22 (23.66)

 

 Yes

306 (79.48)

136 (78.61)

 

76 (81.72)

71 (76.34)

 

Size, n (%)

  

0.469

  

0.088

  ≤ 5

272 (70.75)

88 (50.87)

 

61 (56.99)

49 (52.69)

 

  > 5

113 (29.35)

85 (49.13)

 

40 (43.01)

44 (47.31)

 

Number, n (%)

  

0.07

  

 < 0.001

 Solitary

326 (84.68)

142 (82.08)

 

77 (82.80)

77 (82.80)

 

 Multiple

59 (15.32)

31 (17.92)

 

16 (17.20)

16 (17.20)

 

Tumor capsule, n (%)

  

0.013

  

0.091

 Absence

245 (63.64)

109 (63.01)

 

64 (68.82)

60 (64.52)

 

 Presence

140 (36.37)

64 (36.99)

 

29 (31.18)

33 (35.48)

 

Differential, n (%)

  

0.194

  

0.067

 Good

269 (69.87)

105 (60.69)

 

32 (34.41)

35 (37.63)

 

 Moderate/poor

116 (30.13)

68 (39.31)

 

61 (65.59)

58 (62.37)

 

BCLC, n (%)

  

0.424

  

0.092

 A

260 (67.53)

84 (48.55)

 

51 (54.84)

51 (54.84)

 

 B

108 (28.05)

68 (39.3)

 

37 (39.78)

35 (37.63)

 

 C

17 (4.42)

21 (12.14)

 

5 (5.38)

7 (7.53)

 

GGT, n (%)

  

1.648

  

 < 0.001

  ≤ 50

261 (67.79)

11 (6.36)

 

11 (11.83)

11 (11.82)

 

  > 50

124 (32.21)

162 (93.64)

 

82 (88.17)

82 (88.17)

 

ALBI Grade, n (%)

  

0.251

  

0.024

 A

289 (75.06)

110 (63.58)

 

65 (69.89)

66 (70.97)

 

 B

96 (24.9)

63 (36.42)

 

28 (30.11)

27 (29.03)

 
  1. ALT, Alanine aminotransferase; TB, Total Bilirubin; AFP, α-fetoprotein; BCLC, Barcelona Clinic Liver Cancer staging; GGT, γ-Glutamyl Transpeptidase; ALBI grade, Albumin-Bilirubin Grade